31181839|t|Structural and Conformational Studies on Carboxamides of 5,6-Diaminouracils-Precursors of Biologically Active Xanthine Derivatives.
31181839|a|8-Arylethynylxanthine derivatives are potent, selective adenosine A2A receptor antagonists, which represent (potential) therapeutics for Parkinson's disease, Alzheimer's dementia, and the immunotherapy of cancer. 6-Amino-5-amidouracil derivatives are important precursors for the synthesis of such xanthines. We noticed an unexpected duplication of NMR signals in many of these uracil derivatives. Here, we present a detailed analytical study of structurally diverse 6-amino-5-carboxamidouracils employing dynamic and two-dimensional NMR spectroscopy, density functional theory calculations, and X-ray analysis to explain the unexpected properties of these valuable drug intermediates.
31181839	41	53	Carboxamides	Chemical	-
31181839	57	75	5,6-Diaminouracils	Chemical	MESH:C061549
31181839	110	118	Xanthine	Chemical	MESH:D019820
31181839	132	153	8-Arylethynylxanthine	Chemical	-
31181839	201	210	 receptor	Gene	135
31181839	198	201	A2A	DNAMutation	tmVar:c|SUB|A|2|A;HGVS:c.2A>A;VariantGroup:0
31181839	269	288	Parkinson's disease	Disease	MESH:D010300
31181839	290	310	Alzheimer's dementia	Disease	MESH:D000544
31181839	337	343	cancer	Disease	MESH:D009369
31181839	345	366	6-Amino-5-amidouracil	Chemical	-
31181839	430	439	xanthines	Chemical	MESH:D014970
31181839	510	516	uracil	Chemical	MESH:D014498
31181839	599	627	6-amino-5-carboxamidouracils	Chemical	-
31181839	Association	MESH:D010300	135
31181839	Association	HGVS:c.2A>A	MESH:D000544
31181839	Association	HGVS:c.2A>A	MESH:D010300
31181839	Association	HGVS:c.2A>A	MESH:D009369
31181839	Association	MESH:D009369	135

